Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.16 | €8.35 | 287.062% |
Immunogen Inc. | 5 | 0 | 0 | 0 | €28.97 | - | - |
Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.84 | €13.77 | 1548.474% |
Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.84 | €8.50 | 8.418% |
Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €5.95 | €10.00 | 68.067% |
Catalent Inc. | 1 | 0 | 0 | 0 | €50.37 | €55.00 | 9.192% |
AbbVie Inc. | 22 | 0 | 4 | 0 | €144.84 | €175.11 | 20.899% |
Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
Sarepta Therapeutics | 1 | 0 | 0 | 0 | €113.90 | €130.00 | 14.135% |
MacroGenics Inc. | 13 | 0 | 4 | 0 | €4.18 | €12.42 | 196.957% |
Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.66 | €11.05 | 95.111% |
Repligen Corp. | 13 | 0 | 1 | 0 | €145.90 | €184.76 | 26.635% |
TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €15.20 | €28.06 | 84.611% |
Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €36.98 | €70.00 | 89.317% |
Eli Lilly Corp. | 49 | 0 | 6 | 0 | €748.80 | €786.51 | 5.035% |
Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €1.96 | €8.55 | 336.217% |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.57 | €4.62 | 1.006% |
Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.54 | €12.18 | 379.465% |
VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.59 | €3.00 | 408.475% |
Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.90 | - | - |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €71.04 | €100.00 | 40.766% |
Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €34.00 | €45.98 | 35.235% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.51 | €3.70 | 145.033% |
Merck & Co. Inc. | 28 | 1 | 0 | 0 | €119.00 | €124.92 | 4.977% |